Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

Management of <i>Helicobacter pylori</i> infection—the Maastricht IV/ Florence Consensus Report

Peter Malfertheiner, Françis Mégraud, Colm O’Morain et al. · Gut · 2012 · 2.2K citations · Full text

<i>Helicobacter pylori</i> resistance to antibiotics in Europe and its relationship to antibiotic consumption

Françis Mégraud, Samuel Coenen, Ann Versporten et al. · Gut · 2012 · 825 citations

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Mei‐Jyh Chen et al. · The Lancet · 2012 · 265 citations

Randomised Trial, Gastroenterology, First-line Treatment +3

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

E. Robert Greenberg, Garnet L. Anderson, Douglas R. Morgan et al. · The Lancet · 2011 · 255 citations

Helicobacter Pylori Infection, Antimicrobial Stewardship, Randomised Trial +8

Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance

Javier Molina‐Infante, Marco Romano, Miguel Fernández‐Bermejo et al. · Gastroenterology · 2013 · 197 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +10